In a world first, researchers at the Kennedy Institute, Oxford have mapped the cellular dynamics following treatment with the most commonly used advanced therapy in autoimmune diseases. They have discovered why some patients benefit from this therapy while others do not, potentially paving the way for new therapies. Autoimmune diseases such as inflammatory bowel …
Single-cell RNA-sequencing provides cellular roadmap reveals new paths to treating inflammatory bowel disease
Share.
